Abstract:Methionine Aminopeptidases MetAPs are divalent-cofactor dependent enzymes that are responsible for the cleavage of the initiator Methionine from the nascent polypeptides. MetAPs are classified into two isoforms: namely, MetAP1 and MetAP2. Several studies have revealed that MetAP2 is upregulated in various cancers, and its inhibition has shown to suppress abnormal or excessive blood vessel formation and tumor growth in model organisms. Clinical studies show that the natural product fumagillin, and its analogs are potential inhibitors of MetAP2. However, due to their poor pharmacokinetic properties and neurotoxicities in clinical studies, their further developments have received a great setback. Here, we apply structure-based virtual screening and molecular dynamics methods to identify a new class of potential inhibitors for MetAP2. We screened Otava's Chemical Library, which consists of about 3 200 000 tangible-chemical compounds, and meticulously selected the top 10 of these compounds based on their inhibitory potentials against MetAP2. The top hit compounds subjected to ADMET predictor using 3 independent ADMET prediction programs, were found to be drug-like. To examine the stability of ligand binding mode, and efficacy, the unbound form of MetAP2, its complexes with fumagillin, spiroepoxytriazole, and the best promising compounds compound-3369841 and compound-3368818 were submitted to 100 ns molecular dynamics simulation. Like fumagillin, spiroepoxytriazole, and both compound-3369841 and compound-3368818 showed stable binding mode over time during the simulations. Taken together, these uninherited-fumagillin compounds may serve as new class of inhibitors or provide scaffolds for further optimization towards the design of more potent MetAP2 inhibitors -development of such inhibitors would be essential strategy against various cancer types.

Discovery and structural modification of inhibitors of methionine aminopeptidases from Escherichia coli and Saccharomyces cerevisiae.

Pyridinylpyrimidines selectively inhibit human methionine aminopeptidase-1

Identification of potential inhibitors of human methionine aminopeptidase (type II) for cancer therapy: Structure-based virtual screening, ADMET prediction and molecular dynamics studies

Structural analysis of bengamide derivatives as inhibitors of methionine aminopeptidases

Characterization of Full Length and Truncated Type I Human Methionine Aminopeptidases Expressed from Escherichia Coli

Synthesis of barbiturate-based methionine aminopeptidase-1 inhibitors

Specificity for inhibitors of metal-substituted methionine aminopeptidase.

Pyridinylquinazolines selectively inhibit human methionine aminopeptidase-1 in cells

Identification of promising methionine aminopeptidase enzyme inhibitors: A combine study of comprehensive virtual screening and dynamics simulation study

Ionic immobilization, diversification, and release: application to the generation of a library of methionine aminopeptidase inhibitors

Development of quinoline-based hybrid as inhibitor of methionine aminopeptidase 1 from Leishmania donovani

Methionine aminopeptidases: Potential therapeutic target for microsporidia and other microbes

Design, synthesis and biological evaluation of novel L-lysine ureido derivatives as aminopeptidase N inhibitors.

Type I Methionine Aminopeptidase from Saccharomyces Cerevisiae is a Potential Target for Antifungal Drug Screening.

Synthesis, Molecular Modeling and Biological Evaluation of PSB As Targeted Antibiotics.

Design,synthesis and activity study of aminopeptidase N targeted N-substituted-2,5-dioxopyrrolidin peptidomimetics

Discovery of Potent 1H-Imidazo[4,5-b]pyridine-based C-Met Kinase Inhibitors Via Mechanism-Directed Structural Optimization.

Design and Synthesis of Novel Chloramphenicol Amine Derivatives As Potent Aminopeptidase N (APN/CD13) Inhibitors

Design, Synthesis and Preliminary Activity Evaluation of Novel L-Lysine Derivatives As Aminopeptidase N/Cd13 Inhibitors

Discovery of novel 2-aminopyridine-3-carboxamides as c-Met kinase inhibitors

Design, synthesis and biological evaluation of substituted 3-amino-N-(thiazol-2-yl)pyrazine-2-carboxamides as inhibitors of mycobacterial methionine aminopeptidase 1